We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
(+11%)
Cap. Flow
+$648M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$412M |
| 2 |
Goldman Sachs
GS
|
+$374M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$347M |
| 4 |
Procter & Gamble
PG
|
+$320M |
| 5 |
Coca-Cola
KO
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$400M |
| 2 |
Constellation Brands
STZ
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$286M |
| 4 |
Kenvue
KVUE
|
+$277M |
| 5 |
AbbVie
ABBV
|
+$258M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 13.22% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Financials | 7.66% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRTAW
2276
CALL
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
| $110K | ﹤0.01% |
30,000
| – | – |
|
2277
CI&T Inc
CINT
$409M
| $110K | ﹤0.01% |
26,657
-81,736
| -75% | -$369K |
|
2278
Solarmax Technology
SMXT
$19.1M
| $109K | ﹤0.01% |
+11,913
| New | +$87.2K |
|
|
CAPTW
2279
CALL
DELISTED
Captivision Inc Warrant
CAPTW
| $108K | ﹤0.01% |
23,771
-15,022
| -39% | -$1.5K |
|
2280
CALL
ExxonMobil
XOM
$642B
| $106K | ﹤0.01% |
900
-81,100
| -99% | -$8.49M |
|
|
CLSD
2281
DELISTED
Clearside Biomedical
CLSD
| $105K | ﹤0.01% |
+4,564
| New | +$98.4K |
|
2282
Broadwind
BWEN
$112M
| $104K | ﹤0.01% |
43,849
-52,319
| -54% | -$128K |
|
2283
Beyond Meat
BYND
$283M
| $104K | ﹤0.01% |
+12,518
| New | +$96.3K |
|
|
AKYA
2284
DELISTED
Akoya BioSciences
AKYA
| $103K | ﹤0.01% |
+22,017
| New | +$114K |
|
|
RERE
2285
ATRenew
RERE
$913M
| $102K | ﹤0.01% |
57,885
-94,195
| -62% | -$126K |
|
|
HGASW
2286
CALL
DELISTED
Global Gas Corporation Warrant
HGASW
| $102K | ﹤0.01% |
80,000
-5,317
| -6% | -$181 |
|
2287
Altisource Portfolio Solutions
ASPS
$62.7M
| $99K | ﹤0.01% |
6,380
+4,460
| +232% | +$98.8K |
|
2288
PUT
VanEck Oil Services ETF
OIH
$2.06B
| $97.6K | ﹤0.01% |
+300
| New | +$91K |
|
|
RBOT.WS
2289
CALL
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
| $95.7K | ﹤0.01% |
290,000
-10,000
| -3% | -$909 |
|
2290
Amplify Energy
AMPY
$155M
| $95.2K | ﹤0.01% |
14,400
-64,700
| -82% | -$393K |
|
2291
PUT
ASML
ASML
$636B
| $91.5K | ﹤0.01% |
+100
| New | +$88.7K |
|
2292
Abbott
ABT
$182B
| $90.9K | ﹤0.01% |
800
-138,743
| -99% | -$15.9M |
|
|
LNAI
2293
Lunai Bioworks
LNAI
$10.1M
| $90.8K | ﹤0.01% |
+428
| New | +$115K |
|
|
PDM
2294
Piedmont Realty Trust
PDM
$1.22B
| $90K | ﹤0.01% |
12,800
-377,957
| -97% | -$2.53M |
|
2295
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
| $85K | ﹤0.01% |
+1,800
| New | +$77.3K |
|
|
2296
PUT
ExxonMobil
XOM
$642B
| $82.4K | ﹤0.01% |
700
-235,800
| -100% | -$24.7M |
|
2297
Anixa Biosciences
ANIX
$118M
| $82.3K | ﹤0.01% |
26,372
+15,697
| +147% | +$62.6K |
|
2298
IHS Holding
IHS
$2.77B
| $82K | ﹤0.01% |
23,237
-304,289
| -93% | -$1.04M |
|
|
LUNA
2299
DELISTED
Luna Innovations Incorporated
LUNA
| $76.4K | ﹤0.01% |
+23,800
| New | +$152K |
|
2300
Butterfly Network
BFLY
$1.85B
| $75.8K | ﹤0.01% |
+70,182
| New | +$75.2K |
|
Similar funds
Marshall Wace's Q1 2024 Portfolio in Review
As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
- Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
- Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
- Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
- Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
- Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.
Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.